JUN 16, 2020 9:00 AM PDT

Personal Protein Signatures for Precision Medicine

Speaker
  • Founder, CEO and CSO of Atturos Ltd.
    Biography
      Stephen Pennington who is currently Professor of Proteomics at the University college Dublin School of Medicine & Conway Institute in Dublin, Ireland, as well as Founder, CEO and CSO of Atturos Ltd. He graduated from Imperial College London and earned his PhD in Biochemistry from the University of Cambridge. Steve and his research team are actively engaged in a number of collaborative translational clinical proteomics projects using mass spectrometry. Atturos mission is to deliver advanced diagnostic tests to enable clinicians 'make better clinical decisions'. Atturos first 'in house' product is a patented multimarker test - OCProDx - designed to support men diagnosed with prostate cancer and we'll hear more about that in Steve's presentation.

    Abstract

    It is anticipated that the rapidly emerging era of data-driven precision medicine will require the development and delivery of new protein-based tests. Despite significant advances in the use of mass spectrometry for protein quantification, the implementation of new protein signatures is proving very challenging. Some of these challenges and potential solutions will be outlined in the context the precision medicine-orientated and end user driven approach Atturos is using to develop and deliver new protein signature tests with specific intended utility in chronic diseases.

    For Research Use Only. Not for use in diagnostic procedures.


    Show Resources
    You May Also Like
    FEB 26, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    FEB 19, 2020 11:00 AM PST
    C.E. CREDITS
    FEB 19, 2020 11:00 AM PST
    DATE: February 19, 2020TIME: 11:00am PST, 2:00pm EST...
    JUN 17, 2020 1:30 PM PDT
    C.E. CREDITS
    JUN 17, 2020 1:30 PM PDT
    Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    JUN 09, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    Loading Comments...
    Show Resources